E
EDIRNA
Inactive–/10Traction
An early-stage biotechnology company specializing in RNA editing technology, focusing on precise modifications to RNA sequences to enhance gene expression and therapeutic outcomes. The company aims to address genetic disorders by providing targeted solutions that improve the efficacy of RNA-based treatments.
HQ unknown
- Biotechnology
Updated 4 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- An early-stage biotechnology company specializing in RNA editing technology, focusing on precise modifications to RNA sequences to enhance gene expression and therapeutic outcomes. The company aims to address genetic disorders by providing targeted solutions that improve the efficacy of RNA-based treatments.